|
The European
Commission Research and Enterprise Directorates'
General and EuropaBio, organised a one and a half-day workshop on "European
Biotech Strategy and the New Member States" on November 25th and
26th 2004. The meeting took place at the
UNICE Conference Centre, Avenue Cortenbergh 168,
Brussels.
EuropaBio, the European
Association for Bioindustries, organised a morning session on 25th
November 2004 at EuropaBio, 6,
Avenue de l’Armée, 1040 Brussels.
The industry event preceded the one and a half-day workshop
organised in co-operation with the European Commission. The
participants of this morning session were industry
representatives from the new Members States, national
associations representatives from western and eastern Europe as well
as agencies responsible for innovation and investment.
The workshop brought together
representatives
of the New Member States governments,
representatives of the biotech research and industry communities,
agencies responsible for innovation, research and development (bioclusters),
the European Investment Bank/European Investment Fund and the
European Commission (DG Research/DG Enterprise/DG Regio).
The main goals of this meeting were to inform the New Member States
about the European Strategy for Life Sciences and biotechnology,
launched by the Commission in 2002, and the progress of the
implementation of its action plan, in particular in the areas of
research, innovation and finance.
Input
from the New Member States may help to adapt the existing policy
tools or to develop new ones for an enlarged Europe.
Summary and
conclusions of the meeting
|
European research and its importance for the
European
strategy for Life
Sciences and biotechnology
Manuel HALLEN ,
European Commission,
Directorate Biotechnology, Agriculture and Food Research,
|
|
The European Biotech Strategy – Action Plan and
progress report
http://ec.europa.eu/biotechnology/introduction_en.html
Christian SIEBERT ,
European Commission,
Enterprise Policy, Biotechnology
Johan VANHEMELRIJCK,
EuropaBio, Secretary General
What is the "Life Sciences and Biotechnology strategy
for Europe" ?
Life sciences and biotechnology are widely
recognised to be, after information technology, the next wave of
the knowledge-based economy, creating new opportunities for our
societies and economies.
Therefore in January 2002, The European Commission published a
document
‘Life sciences and biotechnology – a strategy for
Europe’
with a 30 point action plan for the development of
biotechnology in Europe. In March 2002, the European Council
meeting in Barcelona endorsed the strategy and action plan.
The Action Plan is a follow-up to the Lisbon and Stockholm
summits where biotechnology was acknowledged as the backbone of
a knowledge-based economy.
Our democratic societies should offer the necessary safeguards
and channels of dialogue to ensure that the development and
applications of life sciences and biotechnology take place
respecting the fundamental values recognised by the European
Union in the Charter of Fundamental Rights.
The 30 point
action plan involves industry, regulators, science and
society to working together to progress biotechnology in Europe.
The 30 actions are closely inter-related and cover all areas of
importance: legislation, public perception, financing, research,
workforce education, and international aspects.
Second report
on the progress
made on the implementation of the
strategy on life sciences and biotechnology.
Workshop participants who would like to make an input for or
comment on the progress report and/or for the 30 point action
plan for the development of biotechnology in Europe should send
it to:
Mr. Waldemar KÜTT, European Commission DG RTD -
waldemar.kutt@cec.eu.int
Ms. Elena PRATS, European Commission DG ENTR -
elena.prats@cec.eu.int
|
|
National Biotech Strategies
Anna CUMMINS ,
Bioscience Unit, Department of Trade and
Industry,
UK
Gunvor
NIELSEN,
Danish Ministry of Science, Technology
and Innovation, Denmark
Menno HORNING,
Dutch Ministry of Economic Affairs, The Netherlands
A national/regional action plan for biotechnology
Benchmarking of Biotech Policy study
Thomas REISS, Fraunhofer Institut,
Germany
The potential of biotech in the New Member States
Laurent BONTOUX, EU Commission,
Joint Research Centre
|
|
Financing instruments of the European Investment
Bank
John DAVIS , Technical Adviser in
charge of Biotechnologies, representative of the Lending
Operations Directorate, EIB, Luxembourg
|
|
Understanding regional policy and structural
funds
Christine MASON ,
European Commission,
Regional Policy
|
|
Stronger
interregional cooperation
Jaanus PIKANI ,
ScanBalt steering committee chairman
ScanBalt,
Borderless Biotech
http://www.scanbalt.org/
Importance
of coordination between national biotech associations and
bioregions at European level
(*)
Horst
DOMDEY,
Managing Director Bio Tech-Region Munich
BioM AG - Munich BioTech
http://www.bio-m.de/web/index.php4
|
|
What is a technology platform?
Peter KERR ,
European Commission; Research Policy
For
more information on technology platforms please go to:
Framework
Research Program 7th - Open consultation
http://ec.europa.eu/research/future/themes/index_en.html |
|
Plants Genomics and Biotechnology Technology
platform
Karin METZLAFF,
EPSO, Ghent,
Belgium
Full details
of who is involved and where we are on the project are available
on the EPSO website-
www.epsoweb.org
Plants
for the future - Vision paper of the the European platform on
Plant Genomics
|
|
Technology platform on White/Industrial biotech
Maurice FRANSSEN ,
Wageningen
University, The Netherlands
A
European technology platform for sustainable chemistry
|
|
Technology platform on Red Biotech
Irene NORSTEDT ,
European Commission, Director Biotechnology and Health
Research & Karen STRANDGAARD, representative of
EFPIA
European Platform on Innovative Medicines
|
How to build up
a successful national bioscience association
(*)
Aisling BURNAND, Chief Executive Officer of the British
Biotech Association
BIA
(United Kingdom)
http://www.bioindustry.org
Examples of
National Associations from New Member States
(*)
Richard SCHWAB, Chief Executive Officer of Cooperative
Research Centre
Hungarian Biotech Association (Hungary)
http://www.hungarianbiotech.org
Jaanus PIKANI, Chairman of the Estonian National Biotech
Association
Estonian Biotech Association (Estonia)
http://www.biotech.city.ee
(*) Presentations at the EuropaBio industry event
|
European
Biotechnology and the New Member States